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Background: Resistant starch (RS) decreases intestinal inflammation in some settings. We tested the hypothesis
that gut inflammation will be reduced with dietary supplementation with RS in rural Malawian children. Eighteen
stunted 3–5-year-old children were supplemented with 8.5 g/day of RS type 2 for 4 weeks. The fecal samples were
analyzed for the microbiota, the microbiome, short chain fatty acids, metabolome, and proteins indicative of
inflammation before and after the intervention. Subjects served as their own controls.
Results: The consumption of RS changed the composition of the microbiota; at the phylum level Actinobacteria
increased, while Firmicutes decreased. Among the most prevalent genera, Lactobacillus was increased and Roseburia,
Blautia, and Lachnospiracea incertae sedis were decreased. The Shannon H index at the genus level decreased from
2.02 on the habitual diet and 1.76 after the introduction of RS (P < 0.01). Fecal acetate concentration decreased, and
fecal propionate concentration increased after RS administration (−5.2 and 2.0 μmol/g, respectively). Fecal
calprotectin increased from 29 ± 69 to 89 ± 49 μg/g (P = 0.003) after RS was given. The lipopolysaccharide
biosynthesis pathway was upregulated.
Conclusions: Our findings do not support the hypothesis that RS reduces gut inflammation in rural Malawian children.
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Subclinical, chronic gut inflammation, known as envir-
onmental enteric dysfunction (EED), with its associated
dysbiosis has been implicated in growth faltering [1–3].
Dietary interventions to ameliorate EED must be safe,
inexpensive, robust, widely available throughout the de-
veloping world, and exert reliably beneficial effects on
gut health.
Resistant starch (RS) type 2 is present in cereals, tubers,
legumes, and fruits [4]. In animal models, consumption of
RS improves gut integrity and absorption of nutrients and
reduces T cell infiltration of the mucosa [5–7]. In humans,
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article, unless otherwise stated.microbiota and promotes the microbial fermentative pro-
duction of short-chain fatty acids (SCFA), which putatively
reduce gastrointestinal inflammation [8–10]. RS also im-
proves symptoms and reduces pathology in inflammatory
bowel disease [11]. In addition, RS meets the criteria for
safety, durability, and availability as a dietary intervention
to reduce EED. Administration of an RS during an acute
attack of diarrhea reduces duration of diarrhea in adults
with cholera and children [12]. These data compel an
examination of RS as an agent to reduce EED.
In this pilot controlled clinical trial, we tested the hy-
pothesis that among 3–5-year-old rural Malawian children
at high risk for EED and attendant growth stunting, the
introduction of RS to the daily diet for 1 month would
affect changes in the microbiota and microbiome, increaseis distributed under the terms of the Creative Commons Attribution 4.0
ns.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
give appropriate credit to the original author(s) and the source, provide a
indicate if changes were made. The Creative Commons Public Domain
.org/publicdomain/zero/1.0/) applies to the data made available in this
Ordiz et al. Microbiome  (2015) 3:37 Page 2 of 9the fecal content of SCFAs, and reduce markers of gut
inflammation. This study was conducted in conjunction




Fecal starch content was increased in all 18 subjects as
they transitioned from their habitual diet to the habit-
ual diet + RS [13]. The children avidly consumed the
RS-containing donuts, and no adverse effects were
noted, including increased flatulence, which is com-
monly reported by adults who increase dietary RS [14].
Microbiota
Sequences from V1–V3 and V3–V5 regions were com-
bined to yield a more complete picture of the micro-
biota (Additional file 1: Table S2). Significant changes
in the composition of the microbiota were seen at all
phylogenetic classification levels after RS was added to
the diet (Fig. 1). Notably, Actinobacteria increased at
the phylum level, while Firmicutes decreased. Coriobac-
teriaceae were increased and Lachnospiraceae were de-
creased at the family level. Lactobacillus was increased
and Roseburia, Blautia, Lachnospiraceae Unclassified,
Clostridium_XlVa, Oscillibacter, Butyricicoccus, and
Lachnospiracea incertae sedis were decreased at the
genus level (Table 1).51%47%
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Fig. 1 16S RNA bacterial sequences represent in fecal samples from 18 Ma
average values of relative abundance (percentage of sequences) of the mo
fecal microbiotaNo significant changes were noted in the populations of
the Gammaproteobacteria class (0.65 vs. 1.66 %) or the
Enterobacteriaceae family (0.03 vs. 0.16 %), which include
many of the gut microbes thought to induce a host inflam-
matory response. These microbes are Gram-negative bac-
teria, which are frequent food contaminants. These
bacteria contain LPS, which induce gut inflammation in a
mouse model [15]. There was no significant change in the
Gram-positive genus of Enterococcus, another frequent
food contaminant, and which also induces gut inflamma-
tion [15]. The pro-inflammatory cytokines, IL-6 and IL-8,
are increased in the presence of a number of gut taxa, all
belonging to the phylum Proteobacteria [16]. We observed
no significant change in the amount of Proteobacteria in
these children after receiving the intervention. The num-
ber of reads associated with Eubacterium rectale, Parabac-
teroides distasonis, and Ruminococcus bromii were
compared in feces collected on the habitual diet and after
the introduction of RS, but no differences in abundance
were found. The microbiota diversity at the genera level as
assessed by the Shannon H index was 2.02 on the habitual
diet and 1.76 after the introduction of RS (P < 0.01).
Prevotella was the most abundant genus found in
these samples and increased post-intervention (Fig. 1).
The gut microbiota of humans are dominated by the
genus Bacteroides, and can be split into enterotypes,
based on the amount of Bacteroides and whether a























lawian children before and after adding RS to their diet. Pie charts of
st abundant bacterial groups: phyla (a), and genus (b) found in the
Table 1 Listing of all bacterial classifications that exhibited





Bacteroidetes 50.5 ± 14.2 57.6 ± 11.9 0.05
Firmicutes 47.2 ± 13.4 39.0 ± 11.6 0.03
Actinobacteria 0.2 ± 0.1 0.7 ± 1.2 <0.001
Class
Bacteroidia 50.6 ± 14.2 57.7 ± 11.9 0.03
Clostridia 42.4 ± 13.5 31.7 ± 9.2 <0.001
Bacilli 2.3 ± 3.2 4.3 ± 4.3 0.04
Actinobacteria 0.2 ± 0.1 0.7 ± 1.2 0.01
Firmicutes unclassified 0.1 ± 0.1 0.08 ± 0.08 0.02
Order
Bacteroidales 50.7 ± 14.2 57.8 ± 11.9 0.05
Clostridiales 42.5 ± 13.5 31.7 ± 9.2 <0.001
Lactobacillales 2.3 ± 3.2 4.3 ± 4.3 0.01
Coriobacteriales 0.1 ± 0.1 0.7 ± 1.2 <0.001
Bdellovibrionales 0.1 ± 0.2 0.0 ± 0.2 0.04
Enterobacteriales 0.1 ± 0.3 0.8 ± 2.3 0.01
Burkholderiales 0.1 ± 0.1 0.1 ± 0.2 0.04
Alphaproteobacteria 0.0 ± 0.1 0.0 ± 0.0 0.03
Deltaproteobacteria unclassified 0.02 ± 0.04 0.0 ± 0.01 0.02
Family
Lachnospiraceae 21.4 ± 7.4 12.2 ± 5.3 <0.001
Bacteroidaceae 1.2 ± 2.3 0.7 ± 1.5 0.04
Veillonellaceae 0.7 ± 0.7 1.2 ± 1.1 0.05
Acidaminococcaceae 0.6 ± 0.6 0.4 ± 0.6 0.03
Clostridiales unclassified 0.5 ± 0.3 0.2 ± 0.1 <0.001
Lactobacillaceae 0.2 ± 0.3 1.4 ± 2.6 0.04
Coriobacteriaceae 0.1 ± 0.1 0.7 ± 1.2 <0.001
Eubacteriaceae 0.1 ± 0.1 0.06 ± 0.10 0.01
Bdellovibrionaceae 0.1 ± 0.2 0.0 ± 0.2 0.04
Enterobacteriaceae 0.1 ± 0.3 0.8 ± 2.3 0.01
Rikenellaceae 0.1 ± 0.2 0.0 ± 0.2 0.04
Genus
Lachnospiracea_incertae_sedis 5.7 ± 2.9 3.5 ± 2.2 <0.001
Roseburia 4.8 ± 3.2 2.6 ± 1.9 <0.001
Lachnospiraceae unclassified 4.6 ± 2.1 2.2 ± 1.2 <0.001
Blautia 3.5 ± 2.0 2.2 ± 1.6 0.03
Bacteroides 1.2 ± 2.3 0.7 ± 1.5 0.04
Clostridium_XlVa 1.1 ± 0.8 0.6 ± 0.5 <0.001
Coprococcus 0.7 ± 0.5 0.3 ± 0.2 <0.001
Oscillibacter 0.6 ± 0.9 0.3 ± 0.4 <0.001
Butyricicoccus 0.5 ± 0.3 0.3 ± 0.2 <0.001
Clostridium_IV 0.5 ± 0.7 0.3 ± 0.6 0.03
Table 1 Listing of all bacterial classifications that exhibited
changes in the intervention (Continued)
Clostridium_XVIII 0.4 ± 0.6 0.3 ± 0.4 0.02
Catenibacterium 0.3 ± 0.5 0.7 ± 1.0 0.01
Lactobacillus 0.2 ± 0.3 1.4 ± 2.6 0.04
The table shows the average values of relative abundance (percentage of
sequences using both pairs) after adding resistant starch (RS) to the habitual
diet of rural Malawian children. Values expressed as mean ± SD; P value
determined by Wilcoxon Signed Ranks test
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Prevotella [17]. The Prevotella-dominant enterotype is
associated with a long-term diet high in carbohydrates,
like the Malawi diet [18]. Other studies have shown that
Prevotella is predominant in the gut microbiome of chil-
dren from Africa, because of the higher fiber content of
their diet, relative to Italian children [19].
Microbial genomic content
Fifty-four bacterial genes encoding enzymes were found
in greater abundance in the feces while on the habitual
diet compared to the habitual diet + RS, while only four
bacterial genes were found in greater abundance after
RS was added to the diet (Additional file 1: Figure S2).
In Additional file 1: Figure S2, Linear Discriminant
Analysis with Effect size Galaxy server (LEfSe) results are
provided for a comparison of all initial (habitual diet:
green) samples vs. all final (habitual diet + RS: red) sam-
ples from individuals for which we had acceptable samples
for both time points. KEGG identifiers in green are those
enzymes enriched in the habitual diet samples, while those
in red are enriched in habitual diet + RS samples. Larger
absolute linear discriminant analyses values imply greater
enrichment, and allow enriched enzymes to be ranked
within each set. The most enriched enzymes in the ha-
bitual diet set are K06147 (ATP-binding cassette, sub-
family B, bacterial), K02025 and K02026 (both being
multiple sugar transport system permease proteins),
and K00850 (6-phosphofructokinase). These enzymes
are overwhelmingly associated with hits from Eubacter-
ium, Roseburia, and Clostridium_XlVa; all bacterial spe-
cies present in greater numbers in the habitual diet
specimens. The most enriched enzyme in the habitual diet
+ RS set is K07480 (insertion element IS1 protein InsB).
This enzyme is associated with the Escherichia coli. The
most upregulated pathway with the addition of RS to the
habitual diet was lipopolysaccharide biosynthesis (Fig. 2).
Fecal SCFA and small organic molecules
In targeted gas chromatography-mass spectrometry
(GC/MS) of stool, the concentration of acetate decreased
with addition of RS to the diet, while propionate increased
(Table 2). In GC/MS-based metabolomic profiling ana-
lyses, the aggregate population of small organic molecules
Fig. 2 LEfse rank plot of differentially abundant pathways in gut microbiomes initial vs. final samples. LDA scores were given for different
abundance of pathways before (habitual diet: green) and after the resistant starch was added to the habitual diet (habitual diet + RS: red)
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fore consuming the RS diet (Additional file 1: Figure S3).
In particular, butyrate adducts 2-hydroxybutyrate in-
creased 4.3-fold and 3,4 dihydroxybutanoate increased
8.4-fold (both P < 0.001) after RS.
Host inflammatory transcripts and proteins
Fecal calprotectin concentration increased after adding
RS to the diet from 29 ± 69 to 89 ± 49 μg/g (n = 17, P =
0.003 Wilcoxon signed rank test), as well as the host
messenger RNA associated with this protein (Table 3).Table 2 SCFA and metabolites with differential expression in





Total short-chain fatty acids 38.0 ± 8.6 35.9 ± 9.7 0.557
Acetate 23.0 ± 6.4 17.8 ± 6.6 0.003*
Propionate 6.5 ± 2.1 8.5 ± 3.0 0.007*
Butyrate 8.5 ± 2.6 9.7 ± 4.1 0.306
Mean ratio 95 % CI
Metabolite
3,4-Di-hydroxy-butanoate 4.3 [2.6, 5.9]
β-Alanine 5.5 [1.7, 9.3]
2-Hydroxy-butyrate 8.4 [3.6, 13.2]
Malate 70 [1.9, 139]
Citramalate 41 [15, 67]
Phenylacetate 5.1 [2.0, 8.3]
Values expressed as mean ± SD; P value determined by Wilcoxon Signed Ranks
test. The metabolites are expressed as average of the ratio of concentration in
stool after RS versus before RS administration for each child
CI confidence interval
*Significant difference p < 0.05Nine other pro-inflammatory host messages were mea-
sured in the feces while on the habitual diet and again
when RS was added, with no significant changes noted
(Table 3).
Discussion
The addition of RS to the habitual rural Malawian diet
in preschool aged children changed the composition of
the gut microbiota. The changes were modest and did
not clearly produce gut bacteria thought to be anti-
inflammatory. Fecal SCFA composition was altered after
RS, but markers of gut inflammation were not de-
creased. Interestingly, fecal calprotectin was increased
after adding RS to the diet and the bacterial microbiome
showed increased expression in the lipopolysaccharide
synthesis pathway, both of these findings suggesting
subclinical gut inflammation. However, taken together,
these data do not support the hypothesis that dietary RS
reduces EED in this population.
This study was one of the first attempts to use prebi-
otics to improve gut health in sub-Saharan Africa. While
compliance was excellent, changes in the microbiome
did not increase SCFA or reduce fecal host inflammatory
transcripts. The complexity and stability of the micro-
biome seems to be such that it is unlikely to be altered
in a substantial manner with a singular dietary additive
such as 8.5 g/day of RS, at least for a short term.
Limitations of this study are that fecal sampling on ei-
ther the habitual diet or after the addition of RS were
made at a single point in time. Perhaps a more complete
picture of the changes could be seen for a series of sam-
ples collected from each subject. No placebo arm was in-
cluded, so that any temporal changes that occurred
during the 4-week study were not controlled for natural
changes in the gut microbial composition in this age
Table 3 Determination of human mRNAs in fecal samples from Malawian children before and after addition of RS
Transcript Habitual diet Habitual diet + RS P value
Caudal type homeobox 1 0.03 ± 0.01 0.03 ± 0.01 0.424
CKLF-like MARVEL transmembrane domain containing 6 0.02 ± 0.01 0.07 ± 0.09 0.182
Family with sequence similarity 65, member B 0.01 ± 0.01 0.02 ± 0.03 0.779
Major histocompatibility complex, class II, DR alpha 0.29 ± 0.17 0.25 ± 0.14 0.332
Interleukin-1β 0.67 ± 0.73 3.56 ± 6.89 0.053
Interleukin-8 0.93 ± 0.96 2.03 ± 2.90 0.231
S100 calcium-binding protein A8 (calprotectin) 0.24 ± 0.24 1.22 ± 1.84 0.006
Sucrose isomaltase 0.01 ± 0.01 0.02 ± 0.02 0.424
Mitochondrial superoxide dismutase 2 0.65 ± 0.46 1.28 ± 1.25 0.575
Toll-like receptor-4 0.02 ± 0.01 0.09 + 0.11 0.062
The ratio of transcript: GAPDH are reported. Values expressed as mean ± SD; p value were determined by Wilcoxon signed ranks test
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microbiome before and after consumption of RS was
compared with LEfSe, a software that does not account
for the paired nature of the specimens. This results in a
loss of statistical power to detect differences.
The genus composition of the microbiota of these rural
African children on their habitual diet was dominated by
Prevotella, manifesting a P-type community structure,
which has been seen in populations that consume large
amounts of dietary RS [20]. RS is particularly a good nutri-
ent source for Bacteroidetes, with its ‘Sus-like systems’ to
degrade complex carbohydrates with their multiple glycan
branches [21]. Bacteroidetes was the dominant phylum we
observed before and after our intervention. Our primary
finding that the addition of dietary RS type 2 to the estab-
lished P-type community of microbiota reduced diversity
demonstrates the influence of the existing microbiota
community on the effect of a prebiotic intervention.
In previous studies, ingestion of RS was accompanied by
increased numbers of Ruminococcus bromii, Parabacter-
oides distasonis, and Eubacterium rectale in the gut, a
finding that was not seen in our work [22–25]. This speaks
to the complexity of the ecosystem within the human gut
and suggests that changes in the populations of certain
species are contingent upon multiple factors.
The amount of animal source macronutrients provided
by the intervention was quite small, about 4 g/day, as
the doughnuts were primarily composed of corn flour
and soy oil. These animal source nutrients are likely to
be almost completely absorbed in the small bowel and
have little effect on the microbiota.
A previous study using the same RS at a similar dose in
4-year-old Indian children in Vellore for several days
increased fecal acetate, propionate, and butyrate, and the
authors concluded that the benefits of SCFA on colonic
mucosa were likely conferred [26]. Feeding dietary sources
of RS to healthy Australian adults was also associated with
an increase in fecal SCFA [27]. We cannot be sure thatSCFA were not produced in greater quantities after these
Malawian children ingested RS, as the SCFA could have
been absorbed. Our intervention was much longer than
that in the Indian children, and the Malawian children had
more severe stunting and likely harbored different commu-
nities of microbiota, which might account for the observed
differences from the Indian children and Australian adults.
Out of more than 1600 metabolites putatively identified
by mass spectrometry, just six were noted to be differen-
tially expressed before and after the consumption of RS. It
seems unlikely that these were directly administered in the
intervention doughnut, as most of the doughnut was
made from habitual foods and these molecules are not
known to be by-products formed during the cooking
process. Thus, we suspect that these molecules might be
produced by microbiotia whose population was supported
by the RS. PCA analyses clearly show a different population
of metabolites after consumption of RS as well (Additional
file 1: Figure S3). Studies of individual bacterial species in-
troduced into germ-free mice show that rather a given taxa
of microbes giving rise to an increase or decrease in a SCFA
or a metabolite, changes in the metabolome are the result
of the microbiota collectively [28, 29].
The increases in fecal calprotectin were modest but
consistent after RS administration had more calprotec-
tin. A normal fecal calprotectin concentration in chil-
dren is <50 μg/g, while clinical colitis is associated with
concentrations >1000 μg/g, and asymptomatic inflamma-
tory bowel disease with concentrations 100–500 μg/g [30].
While the increases in calprotectin suggest more inflam-
mation after RS starch administration, this increase was
not accompanied by any clinical manifestations.
The reduction in the Shannon H index suggests that
RS reduces diversity in the microbiota. The gut micro-
biome naturally becomes both more diverse and stable
over the first 3 years of life [31, 32]. A loss of diversity in
the gut microbiota has also been associated a greater risk
of malnutrition [33].
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increase in bacterial iron complex outer membrane re-
ceptor protein, which would be expected with a decrease
in luminal iron. Because RS increases iron absorption in
piglets by decreasing the amount of iron available to the
gut bacteria [34], this increase of bacterial iron complex
outer membrane receptor protein could reflect the effort
of the gut bacteria to cope with the decrease in iron
available. Additionally, the upregulation of folate biosyn-
thesis following RS treatment is consistent with the
increased amounts of Faecalibacterium and Prevotella in
the gut microbiota, as Faecalibacterium prausnitzii and
Prevotella ruminicola are involved in folate biosynthesis.
Conclusions
RS does not confer physiologically meaningful changes
on gut biology, or gut microbial content, after short
course treatment. Our data do not preclude the potential
use of other prebiotics, but provide no data in support
of using RS to improve gut health in this sub-Saharan
childhood population.
Methods
Study design and population
Eighteen 3–5-year-old stunted children (8 boys and 10
girls) were selected from the rural village of Masika in the
Machinga District in Malawi for the study. The children
lived in subsistence farming families in unelectrified mud
huts with grass roofs, without access to clean water. Stunt-
ing was defined as height-for-age Z score <−2. The children
consumed a plant based, predominantly maize diet, with an
animal source food <2/month. The 18 children studied
were on average 44 ± 6.7 months old, with weight-for-
height Z score 0.01 ± 0.7, and height-for-age Z score −3.2 ±
0.7 [13].
Fecal samples were collected 1 day before initiating
dietary RS and 28 days after the RS was begun. Each
fecal sample was snap frozen in liquid nitrogen within
minutes of donation and kept at −80 °C until processing.
The study was approved by the Institutional Review
Board from Washington University School of Medicine
in St. Louis and the Research Ethical Committee of
University of Malawi College of Medicine.
Intervention
The free-living Malawian children enrolled in the study
consumed about 8.5 g of RS in addition to their habitual
Malawian diet, using locally produced doughnuts,
known as mandasis, for 4 weeks [13]. Mandasis were
typically consumed once per week by these children in
their habitual diet. Mandasis for the study were made of
white wheat flour, whole fluid milk, eggs, baking powder,
salt, sugar, and RS (Hylon VII, HAMS 70 % amylose,
National Starch and Chemical Company, Bridgewater,New Jersey) and fried in soybean oil. Each mandasi was
40 g and provided approximately 150 kcal, of which had
4 % protein, 26 % fat, 49 % digestible carbohydrate, and
10 % resistant starch. A study aid delivered the mandasis
twice daily to each participant and observed the con-
sumption of the doughnut.
Isolation and characterization of microbiota
Approximately 100 mg of stool was resuspended in
0.5 ml stool lysis buffer (Buffer ATL, Qiagen, Valencia,
California) and disrupted with 2.3 mm-zirconium/silica
beads (Research Products International Corporation,
Mount Prospect, Illinois) in the FastPrep-24 bead beater
(MP Biomedicals, Santa Ana, California) for 2 min with
a speed of 6.5 m/s twice. The tubes were centrifuged and
50 μl proteinase K solution (25 mg/ml, Qiagen, Valencia,
California) was added. The tubes were incubated in a
water bath at 56 °C for 30 min. Then, 20 μl RNase A
(20 μg/μl) was added, mixed, vortexed, and briefly cen-
trifuged before adding 1 ml lysis buffer Easy Mag. The
samples were processed using the NucliSENS easyMAG
“Specific A” (bioMérieux, Durham, NC) following the
manufacturer’s instructions. Of the total nucleic acids,
110 μl were collected and 50 μl (ca. 50–100 ng/μl) were
submitted to The Genome Institute at Washington
University in St Louis.
The V1–V3 hypervariable regions of the 16S rRNA
gene were amplified by PCR using the 27F and 534R
primers “AGAGTTTGATCMTGGCTCAG” and “ATTA
CCGCGGCTGCTGG.” The V3–V5 hypervariable re-
gions were amplified with 357F and 926R primers,
“CCTACGGGAGGCAGCAG” and “CCGTCAATTCM
TTTRAGT” used by the Human Microbiome Project
[35]. The average read depths obtained with the V1–V3
and V3–V5 primers are provided in Additional file 1:
Tables S1 and S2. The degree of overlap for the genera
captured by the V1–V3 and V3–V5 regions are shown
in Additional file 1: Figure S1. The PCR products were
purified and sequenced at the Genome Institute at
Washington University using the Genome Sequencer
Titanium FLX (Roche Diagnostics, Indianapolis, Indiana).
Sample sequences were binned by locating and remov-
ing their tags in flow space, with one mismatch allowed
(sff file). Fasta and qual files were then generated, and the
primers were removed from the 3′ end of the sequence,
allowing one mismatch in addition to primer degeneracies.
Low quality bases were removed using Mothur software
with the parameter trim.seqs(qaverage = 35) [36]. Se-
quences less than 200 bases were removed, and taxonomic
calls were generated for each read using the Ribosomal
Database Project Naïve Bayesian Classifier version 2.5
with training set 9 [37, 38]. Chimeric sequences were iden-
tified and removed using ChimeraSlayer with default
parameters [37].
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RDP-generated taxonomic calls were analyzed using in-
house Perl script to generate sample vs. taxonomy
matrices, where a 0.5 confidence level was required to
accept a call at each taxonomic level and reads with
<0.5 confidence at a level, for example genus, were
considered unclassified at the family level. Because dif-
ferent samples yielded different sequence depth, read
subsampling, or rarefaction, a depth of 1000 reads was
done using the Vegan package in R [39].
Microbiome analysis
Whole genome shotgun libraries were generated and
sequenced on the Illumina HiSeq 2000 platform [40].
The reads generated were 100 bp in length. Illumina
genomic DNA sequence for 37 WGS samples were re-
trieved from the Laboratory Information Management
System database and subject to human contaminant
screening using BMTagger. The non-human reads were
then filtered to remove redundancy (using Picard’s Esti-
mate Library Complexity method (release 1.27)), low qual-
ity reads were trimmed using the TrimBWAStyle.pl script,
which applies the quality trimming logic used by Burrows-
Wheeler Aligner, and finally low complexity reads as
detected by the DUST program were removed. DUST
masks low quality sequence that it finds, and reads were
discarded anytime fewer than 60 unmasked bases
remained after applying DUST.
These cleaned reads were then mapped to the latest
publically available release of the Kyoto Encyclopedia of
Genes and Genomes (KEGG) genes database (v58) using
the MBLASTX program with default parameters [41]. Re-
sults of this mapping were used as input to The Human
Microbiome Project Unified Metabolic Analysis Network
program [42], to obtain pathway and KEGG identifier
abundances. These abundances were finally fed into the
LEfSe [43] and used to calculate enriched pathways and/or
KEGG identifiers between defined groupings of samples.Determination of SCFA
Fecal SCFA content was determined by gas chromatog-
raphy/mass spectrometry (GC/MS) with stable isotope la-
beled internal standards [44]. Samples were thawed,
weighed, and 50 nmol each internal standard was added
(acetate 13C2;d3, propionate-d5 and butyrate
13C4). The
samples were diluted with 1 ml 0.1 mM HCl and extracted
into 500 μl t-butylmethyl ether. A 150-μl aliquot of the
ether layer was introduced into an autosampler insert, and
50 μlN-methyl-N-tert-butyldimethylsilyltrifluoroacetamide
was added. Derivatized samples were analyzed on an
Agilent 7890A GC interfaced to an Agilent 5975C MS. The
GC column used for the study was a HP-5MS (30 m,
0.25 mm i.d., 0.25 μm film coating, P.J. Cobert St. Louis,Missouri). A linear temperature gradient was used. The ini-
tial temperature of 60 °C was held for 3 min and increased
to 300 °C at 15 °C/min before holding at 300 °C for 2 min.
The samples were subjected to electron ionization and the
source temperature, electron energy, and emission current
were 230 °C, 70 eV, and 300 μA, respectively. The injector
and transfer line temperatures were 250 °C.GC/MS-based fecal metabolomic profiling
Of fecal sample, 13–35 mg was suspended in 400 μl isopro-
panol:CH3CN:0.1 % FA (3:3:2), vortexed, and stored over-
night at −20 °C. These extracts were centrifuged, 300 μl
were transferred into an autosampler vial, taken to dryness
under N2, and chemically derivatized using N-Methyl-N-(tr
imethylsilyl)_trifluoroacetamide/CH3CN (1:3) for 2 h at
room temperature. Quality control samples were then pre-
pared by pooling 10 μl from each sample and injected after
every eight samples. Derivatized samples were analyzed as
described above with an initial temperature of 80 °C for
2 min and a 10 °C/min ramp.
Identification and comparison of the metabolites was
made using the Mass Profiler Professional software (Agi-
lent Technologies, Santa Clara, CA). Software modules
were used to display and statistically compare the orthog-
onally transformed complex data matrix using a principal
component analysis (PCA) and a 3-dimensional plot. This
involved converting the observed mass spectra-related
variable matrix (e.g., signal intensity, mass/charge, reten-
tion time, before vs after RS) into a set of linearly uncorre-
lated variables referred to as principal components where
the first principal component accounts for the greatest
amount of variance in the matrix, the second principal
component the second most variance, and the third prin-
cipal component the third most variance, such that these
principal components represent the eigenvectors of the
covariance matrix. This reduces the dimensionality of the
complex data matrix and reveals the structure of
the variable matrix in a manner that displays and con-
siders the variance in the data. The resulting 3-
dimensional PCA plot display clusters of data points
where the amount of overlap between the clusters is a
reflection of the degree of similarity or diversity be-
tween the data sets (before versus after RS).Detection of fecal inflammatory transcripts and proteins
Nucleic acids from 200 mg human stools samples of 18
children were extracted using the NucliSens easyMAG
system (bioMérieux, Durham, NC) and eluted into 110 μl
final volume. Ten different fecal human mRNA transcripts
were quantified using digital droplet PCR with the QX100
Droplet Digital system (BioRad, Hercules, California) and
analyzed in a droplet reader as previously described [45].
Ordiz et al. Microbiome  (2015) 3:37 Page 8 of 9The calprotectin protein was measured in the fecal
samples by using a PhiCAL Fecal Calprotectin Immuno
assay kit (Calpro AS, Norway) and expressed in μg cal-
protectin/g stool.
Statistical analyses
Subjects served as their own controls. For the microbiota,
SCFA, host inflammatory transcripts, and proteins, com-
parisons were made for each of the 18 children between
the habitual diet, and the habitual diet + RS were made
using a Wilcoxon Signed rank test by SPSS ver. 21.0 (IBM
Corp, Armond, NY) statistical software. For fecal metabo-
lites, the ratio of peak area after RS to the habitual diet
was calculated and the distribution of these ratios was
tested for significance by calculating the 95 % confidence
interval using GraphPad Quick Calcs (La Jolla, California).
For all comparisons, a P < 0.05 was considered significant.
All p values were two-tailed.Availabilty of supporting data
The 16S sequences used in this paper is included in an
Additional file 2.
Additional files
Additional file 1: Table S1. Number of 16S rRNA and wide genome
sequences generated per sample. This table shows the number of raw
(unprocessed) reads and the number of reads remaining after analytical
processing of 18 samples from children fed with the habitual diet and
plus the addition of RS. Table S2 Comparison of the number of reads
obtained by V1–V3 and V3–V5 sequencing. Figure S1 Venn diagram
showing the degree of overlap for genera captured with the V1–V3 and
V3–V5 regions. While the majority of taxa are captured by both sets of
primers, the fact that a significant subset were captured by only one
primer set made the use of both sets more valuable. Figure S2 LEfse
rank plot of differentially abundant genes in gut microbiomes initial
samples vs. final samples. LDA scores were given for different abundance
of genes before (habitual diet: green) and after the resistant starch was
added to the habitual diet (habitual diet + RS: red). Figure S3 Principal
component analysis (PCA) plot showing the differential clustering of
metabolites in fecal samples collected before (blue-habitual diet) and
after (red-habitual diet plus RS) the diet supplementation with RS.
Brown circles represent replicate analyses of the pooled quality control
(QC) fecal samples. The tight clustering of these QC replicate analyses
indicates the high reproducibility and low amount of drift associated
with the GC/MS-based fecal metabolomic profiling analyses conducted
over several hours while the individual fecal extracts are analyzed at the
same time, under identical GC/MS conditions, and on the same GC/MS
instrument.
Additional file 2: 16S rRNA raw reads analyzed in this study.
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